Vadim Alexandre discusses N4 Pharma and Spectral MD

Vadim Alexandre, Head of Healthcare a SP Angel talks about N4 Pharma's #N4P recent acquisition of Nanogenics, a company with a complementary lipid and peptide-based delivery system called Liptide®, which it is using to develop a novel siRNA product targeting an unmet clinical need in the ophthalmology market. Vadim also talks about Spectral MD $MDAI that recently listed on the NASDAQ.